- Home
- NRGV vs KRRO Comparison
NRGV vs KRRO Comparison
Compare NRGV & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRGV
- KRRO
- Stock Information
- Founded
- NRGV 2017
- KRRO 2014
- Country
- NRGV United States
- KRRO United States
- Employees
- NRGV N/A
- KRRO N/A
- Industry
- NRGV Industrial Machinery/Components
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- NRGV Miscellaneous
- KRRO Health Care
- Exchange
- NRGV Nasdaq
- KRRO Nasdaq
- Market Cap
- NRGV 190.1M
- KRRO 209.6M
- IPO Year
- NRGV N/A
- KRRO 2019
- Fundamental
- Price
- NRGV $0.76
- KRRO $15.56
- Analyst Decision
- NRGV Buy
- KRRO Strong Buy
- Analyst Count
- NRGV 4
- KRRO 7
- Target Price
- NRGV $1.94
- KRRO $90.67
- AVG Volume (30 Days)
- NRGV 1.2M
- KRRO 102.4K
- Earning Date
- NRGV 05-12-2025
- KRRO 05-07-2025
- Dividend Yield
- NRGV N/A
- KRRO N/A
- EPS Growth
- NRGV N/A
- KRRO N/A
- EPS
- NRGV N/A
- KRRO N/A
- Revenue
- NRGV $46,199,000.00
- KRRO $4,821,000.00
- Revenue This Year
- NRGV $416.66
- KRRO N/A
- Revenue Next Year
- NRGV $44.89
- KRRO $55.56
- P/E Ratio
- NRGV N/A
- KRRO N/A
- Revenue Growth
- NRGV N/A
- KRRO N/A
- 52 Week Low
- NRGV $0.60
- KRRO $11.13
- 52 Week High
- NRGV $2.70
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- NRGV 49.52
- KRRO 45.62
- Support Level
- NRGV $0.67
- KRRO $13.40
- Resistance Level
- NRGV $0.76
- KRRO $22.15
- Average True Range (ATR)
- NRGV 0.07
- KRRO 2.47
- MACD
- NRGV 0.03
- KRRO 0.07
- Stochastic Oscillator
- NRGV 73.56
- KRRO 24.69
About NRGV Energy Vault Holdings Inc.
Energy Vault Holdings Inc is a grid-scale energy storage company that is driving a faster transition to renewable power by solving the intermittence issues that are inherent to the prevalent sources of renewable energy, solar and wind. Geographical presence in United States, China and Other. Majority of its revenue comes from U.S.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.